Log in to save to my catalogue

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1558532904

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

About this item

Full title

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2014-09, Vol.13 (9), p.673-691

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Epigenetic deregulation can underpin the onset and progression of several human diseases.
The expression and/or function of histone deacetylases (HDACs) is often perturbed in cancer, neurological syndromes and immune disorders.
HDACs can be effectively targeted using small-molecule chemical compounds, and more selective agents a...

Alternative Titles

Full title

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1558532904

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1558532904

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd4360

How to access this item